Persist AI
ActiveDeveloping long-lasting drug formulations 50% faster
This company has previously operated under “Persist AI”, “Persist AI Formulations Corp”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.
Founders · 2
When mom got brain cancer, I used to take her for her "infusions". For 4 hours, we would sit there while drug was being infused into her veins and she had horrible nausea and hair loss. I built Persist to eradicate this horrible experience for future patients. We package drugs so that patients take 1 injection per month or year, without an infusion. This lowers the overall dose the patient receives (reducing side-effects), improves compliance, and quality of life.
Career program manager, first time founder. Focus has been in electronics, automation, and manufacturing. Super excited to be part of the YC batch!
Related startups
The AI that delivers pharma R&D decisions in days, not months
AI for drug formulation
